Equibles does not estimate personal net worth.
Get an email with a short summary when Tango Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TNGX alertsBrian Wolpin has spoken on 1 investor event across 1 company, most recently for Tango Therapeutics, Inc. on October 23, 2026. Tango Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tango Therapeutics, Inc. includes Malte Peters (CEO and Board Member), Malte Peters, M.D. (CEO), Barbara Weber (Chairman) and 7 others.
“I appreciate the opportunity to present the data on behalf of all of the investigators and the patients and the team at TANCO. So to start out with, to think about how the standard of care in pancreatic cancer is evolving, really historically this has been a disease treated with chemotherapy.”
Transcript header (unverified)
Biotechnology · Healthcare
